Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Felodipine Sustained-Release Tablet Market Growth 2022-2028

  • LP 4829063
  • 94 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Felodipine Sustained-Release Tablet will have significant change from previous year. According to our (LP Information) latest study, the global Felodipine Sustained-Release Tablet market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Felodipine Sustained-Release Tablet market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Felodipine Sustained-Release Tablet market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Felodipine Sustained-Release Tablet market, reaching US$ million by the year 2028. As for the Europe Felodipine Sustained-Release Tablet landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Felodipine Sustained-Release Tablet players cover Astrazeneca, NanJing Easeheal Phaemaecutical, SHANXI KANGBO BIOLOGICAL PRODUCT, and Lifeon, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Felodipine Sustained-Release Tablet market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

2.5mg Per Tablet

5mg Per Tablet

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Treat High Blood Pressure

Relieve Angina

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Astrazeneca

NanJing Easeheal Phaemaecutical

SHANXI KANGBO BIOLOGICAL PRODUCT

Lifeon

Changzhou Siyao Pharmaceutical

Mylan

Sandoz

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Felodipine Sustained-Release Tablet Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Felodipine Sustained-Release Tablet by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Felodipine Sustained-Release Tablet by Country/Region, 2017, 2022 & 2028

2.2 Felodipine Sustained-Release Tablet Segment by Type

2.2.1 2.5mg Per Tablet

2.2.2 5mg Per Tablet

2.2.3 Others

2.3 Felodipine Sustained-Release Tablet Sales by Type

2.3.1 Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2022)

2.3.2 Global Felodipine Sustained-Release Tablet Revenue and Market Share by Type (2017-2022)

2.3.3 Global Felodipine Sustained-Release Tablet Sale Price by Type (2017-2022)

2.4 Felodipine Sustained-Release Tablet Segment by Application

2.4.1 Treat High Blood Pressure

2.4.2 Relieve Angina

2.4.3 Others

2.5 Felodipine Sustained-Release Tablet Sales by Application

2.5.1 Global Felodipine Sustained-Release Tablet Sale Market Share by Application (2017-2022)

2.5.2 Global Felodipine Sustained-Release Tablet Revenue and Market Share by Application (2017-2022)

2.5.3 Global Felodipine Sustained-Release Tablet Sale Price by Application (2017-2022)

3 Global Felodipine Sustained-Release Tablet by Company

3.1 Global Felodipine Sustained-Release Tablet Breakdown Data by Company

3.1.1 Global Felodipine Sustained-Release Tablet Annual Sales by Company (2020-2022)

3.1.2 Global Felodipine Sustained-Release Tablet Sales Market Share by Company (2020-2022)

3.2 Global Felodipine Sustained-Release Tablet Annual Revenue by Company (2020-2022)

3.2.1 Global Felodipine Sustained-Release Tablet Revenue by Company (2020-2022)

3.2.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Company (2020-2022)

3.3 Global Felodipine Sustained-Release Tablet Sale Price by Company

3.4 Key Manufacturers Felodipine Sustained-Release Tablet Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Felodipine Sustained-Release Tablet Product Location Distribution

3.4.2 Players Felodipine Sustained-Release Tablet Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Felodipine Sustained-Release Tablet by Geographic Region

4.1 World Historic Felodipine Sustained-Release Tablet Market Size by Geographic Region (2017-2022)

4.1.1 Global Felodipine Sustained-Release Tablet Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Felodipine Sustained-Release Tablet Annual Revenue by Geographic Region

4.2 World Historic Felodipine Sustained-Release Tablet Market Size by Country/Region (2017-2022)

4.2.1 Global Felodipine Sustained-Release Tablet Annual Sales by Country/Region (2017-2022)

4.2.2 Global Felodipine Sustained-Release Tablet Annual Revenue by Country/Region

4.3 Americas Felodipine Sustained-Release Tablet Sales Growth

4.4 APAC Felodipine Sustained-Release Tablet Sales Growth

4.5 Europe Felodipine Sustained-Release Tablet Sales Growth

4.6 Middle East & Africa Felodipine Sustained-Release Tablet Sales Growth

5 Americas

5.1 Americas Felodipine Sustained-Release Tablet Sales by Country

5.1.1 Americas Felodipine Sustained-Release Tablet Sales by Country (2017-2022)

5.1.2 Americas Felodipine Sustained-Release Tablet Revenue by Country (2017-2022)

5.2 Americas Felodipine Sustained-Release Tablet Sales by Type

5.3 Americas Felodipine Sustained-Release Tablet Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Felodipine Sustained-Release Tablet Sales by Region

6.1.1 APAC Felodipine Sustained-Release Tablet Sales by Region (2017-2022)

6.1.2 APAC Felodipine Sustained-Release Tablet Revenue by Region (2017-2022)

6.2 APAC Felodipine Sustained-Release Tablet Sales by Type

6.3 APAC Felodipine Sustained-Release Tablet Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Felodipine Sustained-Release Tablet by Country

7.1.1 Europe Felodipine Sustained-Release Tablet Sales by Country (2017-2022)

7.1.2 Europe Felodipine Sustained-Release Tablet Revenue by Country (2017-2022)

7.2 Europe Felodipine Sustained-Release Tablet Sales by Type

7.3 Europe Felodipine Sustained-Release Tablet Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Felodipine Sustained-Release Tablet by Country

8.1.1 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Country (2017-2022)

8.1.2 Middle East & Africa Felodipine Sustained-Release Tablet Revenue by Country (2017-2022)

8.2 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Type

8.3 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Felodipine Sustained-Release Tablet

10.3 Manufacturing Process Analysis of Felodipine Sustained-Release Tablet

10.4 Industry Chain Structure of Felodipine Sustained-Release Tablet

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Felodipine Sustained-Release Tablet Distributors

11.3 Felodipine Sustained-Release Tablet Customer

12 World Forecast Review for Felodipine Sustained-Release Tablet by Geographic Region

12.1 Global Felodipine Sustained-Release Tablet Market Size Forecast by Region

12.1.1 Global Felodipine Sustained-Release Tablet Forecast by Region (2023-2028)

12.1.2 Global Felodipine Sustained-Release Tablet Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Felodipine Sustained-Release Tablet Forecast by Type

12.7 Global Felodipine Sustained-Release Tablet Forecast by Application

13 Key Players Analysis

13.1 Astrazeneca

13.1.1 Astrazeneca Company Information

13.1.2 Astrazeneca Felodipine Sustained-Release Tablet Product Offered

13.1.3 Astrazeneca Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Astrazeneca Main Business Overview

13.1.5 Astrazeneca Latest Developments

13.2 NanJing Easeheal Phaemaecutical

13.2.1 NanJing Easeheal Phaemaecutical Company Information

13.2.2 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Offered

13.2.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 NanJing Easeheal Phaemaecutical Main Business Overview

13.2.5 NanJing Easeheal Phaemaecutical Latest Developments

13.3 SHANXI KANGBO BIOLOGICAL PRODUCT

13.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Company Information

13.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Offered

13.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Main Business Overview

13.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Latest Developments

13.4 Lifeon

13.4.1 Lifeon Company Information

13.4.2 Lifeon Felodipine Sustained-Release Tablet Product Offered

13.4.3 Lifeon Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Lifeon Main Business Overview

13.4.5 Lifeon Latest Developments

13.5 Changzhou Siyao Pharmaceutical

13.5.1 Changzhou Siyao Pharmaceutical Company Information

13.5.2 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Offered

13.5.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Changzhou Siyao Pharmaceutical Main Business Overview

13.5.5 Changzhou Siyao Pharmaceutical Latest Developments

13.6 Mylan

13.6.1 Mylan Company Information

13.6.2 Mylan Felodipine Sustained-Release Tablet Product Offered

13.6.3 Mylan Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Mylan Main Business Overview

13.6.5 Mylan Latest Developments

13.7 Sandoz

13.7.1 Sandoz Company Information

13.7.2 Sandoz Felodipine Sustained-Release Tablet Product Offered

13.7.3 Sandoz Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sandoz Main Business Overview

13.7.5 Sandoz Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Felodipine Sustained-Release Tablet Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Felodipine Sustained-Release Tablet Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 2.5mg Per Tablet

Table 4. Major Players of 5mg Per Tablet

Table 5. Major Players of Others

Table 6. Global Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)

Table 7. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2022)

Table 8. Global Felodipine Sustained-Release Tablet Revenue by Type (2017-2022) & ($ million)

Table 9. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2022)

Table 10. Global Felodipine Sustained-Release Tablet Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)

Table 12. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2022)

Table 13. Global Felodipine Sustained-Release Tablet Revenue by Application (2017-2022)

Table 14. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2017-2022)

Table 15. Global Felodipine Sustained-Release Tablet Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Felodipine Sustained-Release Tablet Sales by Company (2020-2022) & (K Units)

Table 17. Global Felodipine Sustained-Release Tablet Sales Market Share by Company (2020-2022)

Table 18. Global Felodipine Sustained-Release Tablet Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Felodipine Sustained-Release Tablet Revenue Market Share by Company (2020-2022)

Table 20. Global Felodipine Sustained-Release Tablet Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Felodipine Sustained-Release Tablet Producing Area Distribution and Sales Area

Table 22. Players Felodipine Sustained-Release Tablet Products Offered

Table 23. Felodipine Sustained-Release Tablet Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Felodipine Sustained-Release Tablet Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Felodipine Sustained-Release Tablet Sales Market Share Geographic Region (2017-2022)

Table 28. Global Felodipine Sustained-Release Tablet Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Felodipine Sustained-Release Tablet Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Felodipine Sustained-Release Tablet Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Felodipine Sustained-Release Tablet Sales Market Share by Country/Region (2017-2022)

Table 32. Global Felodipine Sustained-Release Tablet Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Felodipine Sustained-Release Tablet Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Felodipine Sustained-Release Tablet Sales by Country (2017-2022) & (K Units)

Table 35. Americas Felodipine Sustained-Release Tablet Sales Market Share by Country (2017-2022)

Table 36. Americas Felodipine Sustained-Release Tablet Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Felodipine Sustained-Release Tablet Revenue Market Share by Country (2017-2022)

Table 38. Americas Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)

Table 39. Americas Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2022)

Table 40. Americas Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)

Table 41. Americas Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2022)

Table 42. APAC Felodipine Sustained-Release Tablet Sales by Region (2017-2022) & (K Units)

Table 43. APAC Felodipine Sustained-Release Tablet Sales Market Share by Region (2017-2022)

Table 44. APAC Felodipine Sustained-Release Tablet Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Felodipine Sustained-Release Tablet Revenue Market Share by Region (2017-2022)

Table 46. APAC Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)

Table 47. APAC Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2022)

Table 48. APAC Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)

Table 49. APAC Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2022)

Table 50. Europe Felodipine Sustained-Release Tablet Sales by Country (2017-2022) & (K Units)

Table 51. Europe Felodipine Sustained-Release Tablet Sales Market Share by Country (2017-2022)

Table 52. Europe Felodipine Sustained-Release Tablet Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Country (2017-2022)

Table 54. Europe Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)

Table 55. Europe Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2022)

Table 56. Europe Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)

Table 57. Europe Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Felodipine Sustained-Release Tablet Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Felodipine Sustained-Release Tablet Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Felodipine Sustained-Release Tablet

Table 67. Key Market Challenges & Risks of Felodipine Sustained-Release Tablet

Table 68. Key Industry Trends of Felodipine Sustained-Release Tablet

Table 69. Felodipine Sustained-Release Tablet Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Felodipine Sustained-Release Tablet Distributors List

Table 72. Felodipine Sustained-Release Tablet Customer List

Table 73. Global Felodipine Sustained-Release Tablet Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Felodipine Sustained-Release Tablet Sales Market Forecast by Region

Table 75. Global Felodipine Sustained-Release Tablet Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Felodipine Sustained-Release Tablet Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Felodipine Sustained-Release Tablet Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Felodipine Sustained-Release Tablet Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Felodipine Sustained-Release Tablet Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Felodipine Sustained-Release Tablet Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Felodipine Sustained-Release Tablet Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Felodipine Sustained-Release Tablet Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Felodipine Sustained-Release Tablet Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Felodipine Sustained-Release Tablet Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Felodipine Sustained-Release Tablet Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Felodipine Sustained-Release Tablet Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Felodipine Sustained-Release Tablet Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Felodipine Sustained-Release Tablet Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Felodipine Sustained-Release Tablet Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Application (2023-2028)

Table 93. Astrazeneca Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors

Table 94. Astrazeneca Felodipine Sustained-Release Tablet Product Offered

Table 95. Astrazeneca Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Astrazeneca Main Business

Table 97. Astrazeneca Latest Developments

Table 98. NanJing Easeheal Phaemaecutical Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors

Table 99. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Offered

Table 100. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. NanJing Easeheal Phaemaecutical Main Business

Table 102. NanJing Easeheal Phaemaecutical Latest Developments

Table 103. SHANXI KANGBO BIOLOGICAL PRODUCT Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors

Table 104. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Offered

Table 105. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. SHANXI KANGBO BIOLOGICAL PRODUCT Main Business

Table 107. SHANXI KANGBO BIOLOGICAL PRODUCT Latest Developments

Table 108. Lifeon Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors

Table 109. Lifeon Felodipine Sustained-Release Tablet Product Offered

Table 110. Lifeon Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Lifeon Main Business

Table 112. Lifeon Latest Developments

Table 113. Changzhou Siyao Pharmaceutical Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors

Table 114. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Offered

Table 115. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Changzhou Siyao Pharmaceutical Main Business

Table 117. Changzhou Siyao Pharmaceutical Latest Developments

Table 118. Mylan Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors

Table 119. Mylan Felodipine Sustained-Release Tablet Product Offered

Table 120. Mylan Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Mylan Main Business

Table 122. Mylan Latest Developments

Table 123. Sandoz Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors

Table 124. Sandoz Felodipine Sustained-Release Tablet Product Offered

Table 125. Sandoz Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Sandoz Main Business

Table 127. Sandoz Latest Developments

List of Figures

Figure 1. Picture of Felodipine Sustained-Release Tablet

Figure 2. Felodipine Sustained-Release Tablet Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Felodipine Sustained-Release Tablet Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Felodipine Sustained-Release Tablet Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Felodipine Sustained-Release Tablet Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 2.5mg Per Tablet

Figure 10. Product Picture of 5mg Per Tablet

Figure 11. Product Picture of Others

Figure 12. Global Felodipine Sustained-Release Tablet Sales Market Share by Type in 2021

Figure 13. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2022)

Figure 14. Felodipine Sustained-Release Tablet Consumed in Treat High Blood Pressure

Figure 15. Global Felodipine Sustained-Release Tablet Market: Treat High Blood Pressure (2017-2022) & (K Units)

Figure 16. Felodipine Sustained-Release Tablet Consumed in Relieve Angina

Figure 17. Global Felodipine Sustained-Release Tablet Market: Relieve Angina (2017-2022) & (K Units)

Figure 18. Felodipine Sustained-Release Tablet Consumed in Others

Figure 19. Global Felodipine Sustained-Release Tablet Market: Others (2017-2022) & (K Units)

Figure 20. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2022)

Figure 21. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application in 2021

Figure 22. Felodipine Sustained-Release Tablet Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Felodipine Sustained-Release Tablet Revenue Market Share by Company in 2021

Figure 24. Global Felodipine Sustained-Release Tablet Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Felodipine Sustained-Release Tablet Revenue Market Share by Geographic Region in 2021

Figure 26. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2017-2022)

Figure 27. Global Felodipine Sustained-Release Tablet Revenue Market Share by Country/Region in 2021

Figure 28. Americas Felodipine Sustained-Release Tablet Sales 2017-2022 (K Units)

Figure 29. Americas Felodipine Sustained-Release Tablet Revenue 2017-2022 ($ Millions)

Figure 30. APAC Felodipine Sustained-Release Tablet Sales 2017-2022 (K Units)

Figure 31. APAC Felodipine Sustained-Release Tablet Revenue 2017-2022 ($ Millions)

Figure 32. Europe Felodipine Sustained-Release Tablet Sales 2017-2022 (K Units)

Figure 33. Europe Felodipine Sustained-Release Tablet Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Felodipine Sustained-Release Tablet Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Felodipine Sustained-Release Tablet Revenue 2017-2022 ($ Millions)

Figure 36. Americas Felodipine Sustained-Release Tablet Sales Market Share by Country in 2021

Figure 37. Americas Felodipine Sustained-Release Tablet Revenue Market Share by Country in 2021

Figure 38. United States Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Felodipine Sustained-Release Tablet Sales Market Share by Region in 2021

Figure 43. APAC Felodipine Sustained-Release Tablet Revenue Market Share by Regions in 2021

Figure 44. China Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Felodipine Sustained-Release Tablet Sales Market Share by Country in 2021

Figure 51. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Country in 2021

Figure 52. Germany Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Felodipine Sustained-Release Tablet Revenue Market Share by Country in 2021

Figure 59. Egypt Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Felodipine Sustained-Release Tablet Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Felodipine Sustained-Release Tablet in 2021

Figure 65. Manufacturing Process Analysis of Felodipine Sustained-Release Tablet

Figure 66. Industry Chain Structure of Felodipine Sustained-Release Tablet

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390